EcoDrugPlus

Glutamate Receptor, Ionotropic, Nmda2d (Epsilon 4)

Ensembl ID : ENSMAUG00000015271
Gene Symbol: GRIN2D
1 Cross references
278 Possible Orthologues:

Glutaminase

Ensembl ID : ENSMAUG00000020709
Gene Symbol: GLS
1 Cross references
305 Possible Orthologues:

Glutathione S-Transferase Pi 1

Ensembl ID : ENSMAUG00000017855
Gene Symbol: GSTP1
2 Cross references
172 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha

Ensembl ID : ENSMAUG00000014364
Gene Symbol: GSK3A
1 Cross references
260 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSMAUG00000015683
Gene Symbol: GSK3B
4 Cross references
241 Possible Orthologues:

Glycoprotein Vi Platelet

Ensembl ID : ENSMAUG00000022015
Gene Symbol: GP6
3 Cross references
135 Possible Orthologues:

Growth Hormone Secretagogue Receptor

Ensembl ID : ENSMAUG00000012511
Gene Symbol: GHSR
4 Cross references
212 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSMAUG00000011689
Gene Symbol: GUCY1A2
4 Cross references
201 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSMAUG00000000232
Gene Symbol: GUCY1B1
4 Cross references
209 Possible Orthologues:

Heat Shock Protein 90 Alpha (Cytosolic), Class B Member 1

Ensembl ID : ENSMAUG00000018422
Gene Symbol: HSP90AB1
1 Cross references
223 Possible Orthologues:

Histamine Receptor H1

Ensembl ID : ENSMAUG00000009874
Gene Symbol: HRH1
4 Cross references
186 Possible Orthologues:

Histamine Receptor H2

Ensembl ID : ENSMAUG00000008111
Gene Symbol: HRH2
4 Cross references
249 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).